
Krazati Coupons & Discount Card - Compare Prices Near You
My prescription
Edit
200MG, Krazati (30 Tablets)
Select pharmacy

Rite Aid
$3741.32
COUPON PRICE
Albertsons
$3805.00
COUPON PRICE
Walgreens
$3863.74
COUPON PRICE
Walmart
$3915.96
COUPON PRICEKrazati savings card
Show this card to your pharmacist
Rite Aid
$3741.32
BIN
ID
PCN
GRP
019876
LHBE472862
CHIPPO
LHX
Powered by
Related KRAS inhibitor prescriptions
Related KRAS inhibitor prescriptions
More prescriptions for lung cancer
Krazati dosage forms
Dosage | Quantity | Price from | Per unit |
---|---|---|---|
200MG | 30 Tablets | $3797.25 | $126.58 |
Krazati Warnings
Krazati (adagrasib) is associated with several potential risks and it is essential to be aware of these while undergoing treatment. Below are important safety warnings and precautions to consider:
Digestive System Issues: Krazati (adagrasib) frequently causes digestive side effects such as nausea, vomiting, or diarrhea, especially within the initial weeks of treatment. While these are usually manageable with medication, in rare cases, severe issues like bleeding, blockages, or inflammation in the gut can occur, potentially becoming life-threatening. If you experience persistent stomach pain, severe nausea, or difficulty retaining food, contact your oncologist immediately. They may adjust your treatment or prescribe additional interventions.
Heart Rhythm Concerns: This medication can alter heart rhythms, leading to QT interval prolongation, which can be serious. Risk factors include personal or family history of heart rhythm abnormalities, low potassium or magnesium, and concurrent use of other QT-prolonging medications. Regular electrocardiograms (EKGs) and blood tests to monitor electrolyte levels will be necessary to ensure safe use.
Liver Health: Krazati (adagrasib) has the potential to cause liver damage, which might not present symptoms initially. Routine blood tests to monitor liver function will be required before starting treatment and monthly for the first three months. Elevated liver enzymes may be detected, indicating possible liver injury, but these often normalize within a few weeks.
Lung Damage: Although uncommon, lung damage can occur and may be severe. Symptoms typically appear about three months into treatment but can arise sooner or later. Report any new or worsening cough, shortness of breath, or fever to your oncologist promptly. Temporary discontinuation of the medication may be necessary to assess lung health.
It is crucial to maintain open communication with your healthcare provider throughout your treatment with Krazati (adagrasib) to manage these potential risks effectively.
Krazati Side Effects
When taking this medication, some individuals may experience common side effects such as diarrhea, nausea, fatigue, vomiting, and muscle or joint pain. These are generally mild but can become bothersome. It's helpful to manage these symptoms by eating small meals and adjusting activity levels. If symptoms persist or worsen, consulting with a healthcare provider is advised.
Serious side effects, although rare, require immediate medical attention. These include severe digestive issues like persistent stomach pain, black stools, or vomit resembling coffee grounds, which may indicate internal bleeding. Life-threatening heart problems may present as chest pain, shortness of breath, or an irregular heartbeat. Signs of liver damage include persistent nausea, yellowing of the skin or eyes, and dark urine. Additionally, this medication can cause severe lung issues, presenting as a new or worsening cough, shortness of breath, or fever.
Other effects to be aware of include dizziness, constipation, and swelling of hands or feet. If you notice symptoms like a rash, severe dizziness, or difficulty breathing, these may indicate an allergic reaction, which is rare but requires urgent care. Always report new or concerning symptoms to a healthcare professional to ensure your safety and well-being.
Krazati Interactions
Is Krazati chemotherapy or immunotherapy?
Krazati is not classified as chemotherapy or immunotherapy. It is a targeted therapy, specifically a KRAS G12C inhibitor, used in the treatment of certain types of cancer.
What is Krazati used for?
Krazati is used for the treatment of non-small cell lung cancer (NSCLC) in patients who have a specific mutation in the KRAS G12C gene. It is typically prescribed when the cancer has spread to other parts of the body or cannot be surgically removed, and after the patient has received at least one prior systemic therapy.
Does Krazati shrink tumors?
Krazati, also known as adagrasib, is a medication that has shown the ability to shrink tumors in certain patients with specific types of cancer. It is particularly used in cases where tumors have a KRAS G12C mutation. The effectiveness of Krazati in shrinking tumors can vary depending on individual patient factors and the specific characteristics of the cancer. It is important for patients to discuss treatment options and potential outcomes with their healthcare provider.
Is Krazati chemotherapy?
Krazati is not classified as chemotherapy. It is a targeted therapy medication used to treat certain types of cancer by specifically inhibiting the KRAS G12C mutation.
How much does Krazati cost?
The cost of Krazati can vary depending on factors such as the pharmacy, location, insurance coverage, and any available discounts or assistance programs. It is recommended to contact a local pharmacy or healthcare provider for the most accurate and up-to-date pricing information. Additionally, patients may inquire about financial assistance programs that could help reduce the cost.